D-0249-2018 Class III Terminated
FDA drug recall D-0249-2018 was initiated by Taro Pharmaceuticals U.S.A., Inc. on Dec 21, 2017 and is designated Class III. Reason for recall: Failed Content Uniformity Specifications The recall status is terminated (terminated Sep 21, 2020). Affected quantity: 27,792 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 7, 2018
- Initiation Date
- Dec 21, 2017
- Termination Date
- Sep 21, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 27,792 tubes
Product description
Clobetasol Propionate Cream USP, 0.05% 60 g tube, Rx only Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761 Dist. by : Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532 UPC 351672125837 NDC 51672-1258-3
Reason for recall
Failed Content Uniformity Specifications
Distribution pattern
Nationwide
Code information
Lot 311235, exp Sept 2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0249-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026